An increasing number of firms are rushing to manufacture hydroxychloroquine (HCQ), the anti-malarial drug being used widely in the treatment of Covid-19 patients across the world, and now India, too. The Food and Drug Control Administration (FDCA) of Gujarat issued permits to 68 pharmaceutical firms to manufacture HCQ tablets in the state. “In past one and a half months, 68 pharmaceutical companies have received product licences to make HCQ tablets of varied dosages in Gujarat,” HG Koshia, commissioner of Gujarat FDCA, said. Companies like Sun Pharma, Intas Pharmaceuticals, Saga Lifesciences Limited, Norris Medicines, Ellis Pharmaceuticals, Jaimin Remedies, and Lincoln Pharma...